Chemours Invested Capital vs Earnings before Tax Analysis
CC Stock | USD 27.03 0.05 0.18% |
Trend analysis of Chemours Co balance sheet accounts such as Total Assets of 7.5 B or Other Current Liabilities of 1.3 B provides information on Chemours' total assets, liabilities, and equity, which is the actual value of Chemours to its prevalent stockholders. By breaking down trends over time using Chemours balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Chemours |
About Chemours Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Chemours at a specified time, usually calculated after every quarter, six months, or one year. Chemours Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Chemours and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Chemours currently owns. An asset can also be divided into two categories, current and non-current.
Chemours Balance Sheet Chart
Chemours Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Chemours uses and utilizes its capital. It also shows what exactly a company owns and owes.
At present, Chemours' Total Stockholder Equity is projected to decrease significantly based on the last few years of reporting. The current year's Property Plant And Equipment Net is expected to grow to about 3.6 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 140.1 M. Add Fundamental
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Total Assets
Total assets refers to the total amount of Chemours assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Chemours books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Chemours balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Chemours Co are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from Chemours' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Chemours current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. At present, Chemours' Enterprise Value Multiple is projected to increase significantly based on the last few years of reporting.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.4B | 1.6B | 1.3B | 1.2B | Total Revenue | 6.3B | 6.8B | 6.0B | 5.1B |
Chemours fundamental ratios Correlations
Click cells to compare fundamentals
Chemours Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Chemours fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 164.8M | 166.3M | 168.7M | 158.3M | 148.9M | 140.1M | |
Total Assets | 7.3B | 7.1B | 7.6B | 7.6B | 8.3B | 7.5B | |
Other Current Liab | 477M | 537M | 668M | 554M | 1.2B | 1.3B | |
Total Current Liabilities | 1.5B | 1.4B | 1.9B | 1.9B | 2.5B | 1.8B | |
Total Stockholder Equity | 689M | 813M | 1.1B | 1.1B | 737M | 1.1B | |
Other Liab | 751M | 626M | 707M | 854M | 982.1M | 711.9M | |
Property Plant And Equipment Net | 3.9B | 3.7B | 3.4B | 3.4B | 3.5B | 3.6B | |
Accounts Payable | 923M | 820M | 1.2B | 1.3B | 1.1B | 1.1B | |
Non Current Assets Total | 4.5B | 4.4B | 4.2B | 4.4B | 4.4B | 4.4B | |
Non Currrent Assets Other | 391M | 252M | 310M | 573M | 374M | 416.1M | |
Other Assets | 292M | 405M | 547M | 725M | 833.8M | 424.1M | |
Long Term Debt | 4.0B | 4.0B | 3.7B | 3.6B | 4.0B | 3.2B | |
Net Receivables | 674M | 511M | 720M | 626M | 610M | 602.4M | |
Liabilities And Stockholders Equity | 7.3B | 7.1B | 7.6B | 7.6B | 8.3B | 7.5B | |
Non Current Liabilities Total | 5.0B | 4.8B | 4.6B | 4.6B | 5.0B | 4.1B | |
Inventory | 1.1B | 939M | 1.1B | 1.4B | 1.4B | 1.2B | |
Other Current Assets | 81M | 78M | 75M | 82M | 66M | 64.8M | |
Other Stockholder Equity | (213M) | (182M) | (303M) | (722M) | (773M) | (734.4M) | |
Total Liab | 6.6B | 6.3B | 6.5B | 6.5B | 7.5B | 6.0B | |
Property Plant And Equipment Gross | 3.9B | 3.7B | 9.2B | 9.4B | 9.6B | 5.2B | |
Total Current Assets | 2.8B | 2.6B | 3.3B | 3.2B | 3.8B | 3.0B | |
Accumulated Other Comprehensive Income | (349M) | (310M) | (364M) | (343M) | (274M) | (287.7M) | |
Short Term Debt | 13M | 134M | 78M | 25M | 106M | 86.1M | |
Intangible Assets | 28M | 21M | 14M | 6M | 3M | 2.9M | |
Property Plant Equipment | 3.9B | 3.5B | 3.4B | 3.2B | 3.6B | 3.5B | |
Net Tangible Assets | 515M | 646M | 973M | 992M | 892.8M | 710.5M | |
Retained Earnings | 1.2B | 1.3B | 1.7B | 2.2B | 1.8B | 1.1B | |
Cash | 943M | 1.1B | 1.5B | 1.1B | 1.8B | 1.2B | |
Deferred Long Term Liab | 148M | 36M | 49M | 61M | 54.9M | 96.1M | |
Long Term Investments | 162M | 167M | 169M | 175M | 158M | 171.6M | |
Short Long Term Debt | 13M | 134M | 21M | 25M | 51M | 41.5M | |
Short Long Term Debt Total | 4.4B | 4.3B | 3.9B | 3.8B | 4.3B | 4.4B | |
Net Debt | 3.5B | 3.2B | 2.5B | 2.7B | 2.5B | 2.3B | |
Cash And Short Term Investments | 943M | 1.1B | 1.5B | 1.1B | 1.8B | 1.3B | |
Retained Earnings Total Equity | 1.2B | 1.3B | 1.7B | 2.2B | 2.5B | 2.6B | |
Long Term Debt Total | 4.0B | 4.0B | 3.7B | 3.6B | 3.2B | 3.1B | |
Capital Surpluse | 859M | 890M | 944M | 1.0B | 1.2B | 958.4M |
Pair Trading with Chemours
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemours position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will appreciate offsetting losses from the drop in the long position's value.Moving against Chemours Stock
0.59 | ECL | Ecolab Inc Earnings Call This Week | PairCorr |
0.58 | DNMR | Danimer Scientific Financial Report 8th of May 2024 | PairCorr |
0.54 | ASH | Ashland Global Holdings Earnings Call This Week | PairCorr |
0.53 | FEAM | 5E Advanced Materials Financial Report 9th of May 2024 | PairCorr |
0.5 | CBT | Cabot Financial Report 13th of May 2024 | PairCorr |
The ability to find closely correlated positions to Chemours could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemours when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemours - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemours Co to buy it.
The correlation of Chemours is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemours moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemours moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chemours can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.91) | Dividend Share 1 | Earnings Share (1.60) | Revenue Per Share 40.473 | Quarterly Revenue Growth 0.017 |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.